VGG7185A1286
© Globe Newswire
16.12.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital Strategic Investment in Alpha Liquid Terminal Unveils "The Financial Terminal for the Telegram Economy"
News Preview
AlphaTON Capital Strategic Investment in Alpha Liquid Terminal Unveils "The Financial Terminal for the Telegram Economy"...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.12.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital Secures First NVIDIA B300 Chips with Supermicro HGX Systems
News Preview
AlphaTON Capital Secures First NVIDIA B300 Chips with Supermicro HGX Systems...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.12.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital Corp Announces First Major Data Center Agreement with atNorth, Securing 2.2 MW of High-Performance Computing Capacity in Sweden
News Preview
AlphaTON Capital Corp Announces First Major Data Center Agreement with atNorth, Securing 2.2 MW of High-Performance Computing Capacity in Sweden...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
08.12.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital Deploys First H200 GPUs on Cocoon AI Network, Launches Revolutionary #OwnYourNode Program to Democratize AI Infrastructure Ownership
News Preview
AlphaTON Capital Deploys First H200 GPUs on Cocoon AI Network, Launches Revolutionary #OwnYourNode Program to Democratize AI Infrastructure Ownership...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
05.12.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital to Reveal 2026 Technical Strategy in Landmark Inaugural AMA Event
News Preview
Join the Live “Ask Me Anything” with AlphaTON CTO: Thursday, December 11, 2025 at 4:30 PM UTC on X and Telegram Voice Chat...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital Secures $82.5 Million Strategic GPU Infrastructure to Power Privacy-First Decentralized Artificial Intelligence Cluster after Successful Pilot Launch of Telegram’s Cocoon AI
News Preview
This Deal adds $70M of Nvidia GPUs to AlphaTON’s Balance Sheet, combining with the $27M Digital Asset Treasury to total $97M in Total Assets. This Deal adds $70M of Nvidia GPUs to AlphaTON’s Balance Sheet, combining with the $27M Digital Asset Treasury to total $97M in Total Assets....
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital Announces $82.5 Million Strategic GPU Infrastructure Investment to Power Privacy-First Decentralized AI after Successful Pilot Launch of Telegram’s Cocoon AI
News Preview
This Deal adds $70M of Nvidia GPUs to AlphaTON’s Balance Sheet, combining with the $27M Digital Asset Treasury to total $97M in Total Assets.Do This Deal adds $70M of Nvidia GPUs to AlphaTON’s Balance Sheet, combining with the $27M Digital Asset Treasury to total $97M in Total Assets.Do...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.11.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital (Nasdaq: ATON) Issues Shareholder Update on Balance Sheet Assets and Strategic Ecosystem Expansion Clarification and Correction
News Preview
AlphaTON Capital has No Equity Line Financing with ATW Partners or any other provider. ATW Partners is not an investor whatsoever. AlphaTON Capital has never drawn down the entire Bitgo facility and has continued to manage leverage at 7% Debt to Equity Ratio. AlphaTON Capital has No Equity Line Financing with ATW Partners or any other provider. AT...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.11.2025
PRTG
LISTED
NASDAQ
AlphaTON Bolsters Tech Leadership with New CTO to Drive AI Growth
News Preview
Blockchain and AI veteran Logan Ryan Golema takes the helm as CTO to accelerate the company's TON ecosystem and Cocoon AI projects Blockchain and AI veteran Logan Ryan Golema takes the helm as CTO to accelerate the company's TON ecosystem and Cocoon AI projects...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.11.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital (Nasdaq: ATON) Issues Shareholder Update on Balance Sheet Assets and Strategic Ecosystem Expansion
News Preview
Provides Detailed Breakdown of TON Holdings, Strategic Acquisitions, and Partnerships Following $71 Million Financing including $18.5 Million in equity financing from financing partnerships to launch the Artificial Intelligence Compute Program and Telegram Cocoon Initiative Provides Detailed Breakdown of TON Holdings, Strategic Acquisitions, and Pa...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.11.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital Names P2P.org as Institutional Staking Partner to Accelerate TON Treasury Yield Strategy
News Preview
Partnership enables non-custodial staking of TON tokens through BitGo integration, advancing AlphaTON's yield generation strategy Partnership enables non-custodial staking of TON tokens through BitGo integration, advancing AlphaTON's yield generation strategy...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.11.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital Selects P2P.org as First Institutional Staking Partner for TON Treasury Operations
News Preview
Partnership enables non-custodial staking of TON tokens through BitGo integration, advancing AlphaTON's yield generation strategy Partnership enables non-custodial staking of TON tokens through BitGo integration, advancing AlphaTON's yield generation strategy...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
13.11.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital and SingularityNET Join Forces to Accelerate Telegram’s Cocoon AI – Growing the Ethical, Decentralized AI Ecosystem
News Preview
Strategic Partnership Brings Sustainable, Decentralized Computing Power to Privacy-Preserving AI Through Hydroelectric-Powered Data Centers Strategic Partnership Brings Sustainable, Decentralized Computing Power to Privacy-Preserving AI Through Hydroelectric-Powered Data Centers...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.11.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital Accelerates Global Growth with Strategic Appointment of William De’Ath as Chief Partnership Officer
News Preview
Driving Global Partnerships, Institutional Adoption, and TON Mastercard Launch Driving Global Partnerships, Institutional Adoption, and TON Mastercard Launch...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.11.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital Accelerates Global Growth with Strategic Appointment of William De’Ath as Chief Partnership Officer
News Preview
Driving Global Partnerships, Institutional Adoption, and the TON Mastercard Launch Driving Global Partnerships, Institutional Adoption, and the TON Mastercard Launch...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
PRTG
LISTED
NASDAQ
Complete Tumor Regressions Observed in Preclinical Models with Co-administration of Cyncado’s A2B and A2A Receptor Antagonists and Cancer Vaccines
News Preview
Data from studies conducted by investigators at the National Cancer Institute at NCI laboratories, part of a multi-year research effort, will be presented at SITC Data from studies conducted by investigators at the National Cancer Institute at NCI laboratories, part of a multi-year research effort, will be presented at SITC...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital to Acquire Premier Crypto Newswire Blockchain Wire, Cementing Dominance in Digital Asset Communications via the Telegram Ecosystem
News Preview
The Acquisition focuses the Top Crypto News Platform to Expand Verifiable News Distribution to Telegram’s 1+ Billion Users The Acquisition focuses the Top Crypto News Platform to Expand Verifiable News Distribution to Telegram’s 1+ Billion Users...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
PRTG
LISTED
NASDAQ
DAT ALERT: AlphaTON Capital Acquires 300,000 additional TON
News Preview
London, UK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp ("AlphaTON Capital" or the "Company") (Nasdaq: ATON) - AlphaTON Capital, a leading investment firm focused on disruptive technologies, today announced it has acquired an additional 300,000 TON Coin to add to its TON Digital Asset Treasury....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
PRTG
LISTED
NASDAQ
Brittany Kaiser to Present at SALT London 2025 on DeFi, Tokenization, and Digital Asset Treasuries
News Preview
Part of AlphaTON Capital’s global investor roadshow and world tour, bridging crypto innovation with traditional finance across major financial hubs Part of AlphaTON Capital’s global investor roadshow and world tour, bridging crypto innovation with traditional finance across major financial hubs...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital Corp Announces Strategic Joint Venture with Pago Pay and with ALT5 Sigma to Launch Crypto-Enabled TON Mastercard
News Preview
Partnership Brings First Mastercard-Approved TON Card Program Enabling Native Cryptocurrency Spending from Digital Wallets with ALT5 Integration Partnership Brings First Mastercard-Approved TON Card Program Enabling Native Cryptocurrency Spending from Digital Wallets with ALT5 Integration...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital Kicks Off Global World Tour with Investor Breakfast at Nasdaq MarketSite
News Preview
Event to Feature Brittany Kaiser, Enzo Villani, and Michael Terpin Introducing “A New Frontier in Open Finance” Event to Feature Brittany Kaiser, Enzo Villani, and Michael Terpin Introducing “A New Frontier in Open Finance”...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital Announces Strategic Investment in GPU Infrastructure to Power Cocoon Decentralized AI Network
News Preview
Company to Deploy Significant GPU and Data Center Resources Following Cocoon's Launch Announcement at Blockchain Life Company to Deploy Significant GPU and Data Center Resources Following Cocoon's Launch Announcement at Blockchain Life...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital CEO Brittany Kaiser to Speak at “Future of Money, Governance, and the Law” Summit on Capitol Hill, October 30, 2025
News Preview
Washington, DC, Oct. 27, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital (NASDAQ: ATON) is proud to announce that Brittany Kaiser, CEO, will be a featured speaker at the Future of Money, Governance, and the Law (FoMGL) summit, taking place on Capitol Hill on October 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
25.10.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital and Cyncado Therapeutics Share New Mesothelioma Data Supporting TT-4’s Path to First- Patient Dosing
News Preview
Poster presented today in Boston shows direct anti-tumor activity in mesothelioma models, reduced tumor PD-L1 alongside decreased pCREB, and strong TT-4 monotherapy activity with added benefit in anti-PD-1 combinations; TT-4 remains on track for Q1 2026 first-patient dosing Poster presented today in Boston shows direct anti-tumor activity in mesoth...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital Appoints Wes Levitt as Chief Financial Officer
News Preview
New York, NY, Oct. 24, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp. (NASDAQ: ATON) (“AlphaTON” or the “Company”), a specialized digital asset treasury company building the TON ecosystem, today announced the appointment of Wes Levitt as Chief Financial Officer (CFO), effective immediately....
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital Joins Blockchain Game Alliance (BGA)
News Preview
Move Deepens Telegram/TON Gaming Strategy Following Intent to Acquire 51% of GAMEE Move Deepens Telegram/TON Gaming Strategy Following Intent to Acquire 51% of GAMEE...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
PRTG
LISTED
NASDAQ
AACR Abstract: First Evidence that Selective A2B Receptor Inhibition Lowers PD-L1 Tumor Expression and also Directly Suppresses Mesothelioma Tumor Growth
News Preview
Abstract published today reports reduced adenosine-mediated PD-L1 in a human epithelioid mesothelioma cell line linked to decreased CREB phosphorylation (pCREB). In vivo, TT-4 monotherapy outperformed anti-PD-1 and the combination was superior to either agent alone. Additional data will be presented with the poster on Saturday, October 25 Abstract...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.10.2025
PRTG
LISTED
NASDAQ
Enzo Villani, Chief Investment Officer of AlphaTON Capital, to Speak at the Vatican’s 10th Anniversary World Changers Summit
News Preview
Vatican City, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Enzo Villani, Chief Investment Officer of AlphaTON Capital (NASDAQ: ATON), has been invited to speak at the 10th Anniversary of the IASC World Changers Summit, held at the historic Casina Pio IV within Vatican City, home of the Pontifical Academy of Sciences. This prestigious gathering brings togeth...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital CEO Brittany Kaiser and SkyBridge Capital Founder Anthony Scaramucci Join Schwab Network’s Trading 360 to Discuss Crypto Innovation and Cancer Research Funding
News Preview
Dover, DE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp. (Nasdaq: ATON) today announced that its CEO, Brittany Kaiser, will appear alongside Anthony Scaramucci, Founder of SkyBridge Capital and SALT, on Schwab Network’s Trading 360 with Marley Kayden on Tuesday, October 14 at 11:30 a.m. ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital Launches AI Vertical with MorpheusAI to Accelerate Agentic AI Development on TON and Telegram
News Preview
Landmark Strategic Partnership Establishes Morpheus as Preferred AI Infrastructure Provider for AlphaTON's Portfolio Companies Landmark Strategic Partnership Establishes Morpheus as Preferred AI Infrastructure Provider for AlphaTON's Portfolio Companies...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
PRTG
LISTED
NASDAQ
Market Alert: AlphaTON Capital Continues in Growth Mode and Purchases an additional 300,000 TON
News Preview
Dover, DE, Oct. 12, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp. (Nasdaq: ATON) stated that during the market conditions of the past week, AlphaTON Capital is still expanding its TON Treasury, purchasing an additional 300,000 TON off the open market today, adding to the 1.1million TON purchased off the open market last week. With zero liquidat...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital Receives Nasdaq Congratulations for Groundbreaking Cancer Research Tokenization Initiative
News Preview
New York, NY, Oct. 10, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital (NASDAQ: ATON), a specialized digital asset treasury company focused on developing the TON and Telegram ecosystem, and new pioneer in blockchain-based healthcare financing, today announced that Nasdaq has publicly congratulated the company on its innovative approach to funding canc...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital and Subsidiary Cyncado Therapeutics Pioneer Convergence of Digital Assets and Oncology Innovation: Exploring Tokenization Framework for Mesothelioma Program as it Advances Toward Q1 2026 First Patient Dosing
News Preview
Landmark Initiative Positions AlphaTON at Forefront of Decentralized Science (DeSci) Movement, Leveraging TON Infrastructure to Accelerate Life-Saving Cancer Research Landmark Initiative Positions AlphaTON at Forefront of Decentralized Science (DeSci) Movement, Leveraging TON Infrastructure to Accelerate Life-Saving Cancer Research...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital Corp Successfully Closes $71 million Financing and Completes Initial TON Token Acquisition
News Preview
AlphaTON Capital Corp Successfully Closes $71 million Financing and Completes Initial TON Token Acquisition...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
PRTG
LISTED
NASDAQ
AlphaTON Capital Corp Launches TON Digital Asset Treasury Strategy for the Telegram Ecosystem
News Preview
AlphaTON Capital Corp Launches TON Digital Asset Treasury Strategy for the Telegram Ecosystem...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.07.2025
PRTG
LISTED
NASDAQ
Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025
News Preview
Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.06.2025
PRTG
LISTED
NASDAQ
Portage Biotech Regains Full Compliance with Nasdaq Continued Listing Requirements
News Preview
Portage Biotech Inc. received notice from The Nasdaq Stock Market, LLC, indicating that the Company has regained compliance....
Themefolio
Profiler
Peergroup
© Globe Newswire
09.06.2025
PRTG
LISTED
NASDAQ
Portage Biotech and Compedica Stock-for-Stock Exchange
News Preview
Portage Biotech and Compedica Stock-for-Stock Exchange...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.03.2025
PRTG
LISTED
NASDAQ
Portage Biotech Reports Promising Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7
News Preview
Portage Biotech Reports Promising Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.03.2025
PRTG
LISTED
NASDAQ
Portage Biotech Resumes Enrollment in Final Cohort of Dose Escalation for Port-6 in ADPORT-601 Trial
News Preview
Encouraging Safety Profile Supports Progression Toward First Dual-Administration of Selective A2A and A2B Antagonists in Patients Encouraging Safety Profile Supports Progression Toward First Dual-Administration of Selective A2A and A2B Antagonists in Patients...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.02.2025
PRTG
LISTED
NASDAQ
Portage Biotech Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements
News Preview
Portage Biotech receives extension of time to attain compliance with stock exchange continued listing requirements...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.01.2025
PRTG
LISTED
NASDAQ
Portage Biotech Announces Completion of $2.15 Million Private Financing
News Preview
On January 29, 2025, Portage Biotech Inc. (the “Company”) completed the sale of 524,390 ordinary shares for aggregate proceeds of US$2,150,000....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.01.2025
PRTG
LISTED
NASDAQ
Portage Biotech Announce Re-Launch of Adenosine Subsidiary as Independently Managed Company; Appointment of Peter Molloy to Lead New Company
News Preview
Portage Biotech Announce Re-Launch of Adenosine Subsidiary as Independently Managed Company; Appointment of Peter Molloy to Lead New Company...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.12.2024
PRTG
LISTED
NASDAQ
Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd
News Preview
Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.12.2024
PRTG
LISTED
NASDAQ
Portage Biotech Announces Receipt of Nasdaq Noncompliance Letter
News Preview
Portage Biotech announces receipt of Nasdaq noncompliance letter...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2024
PRTG
LISTED
NASDAQ
Portage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024
News Preview
Portage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2024
PRTG
LISTED
NASDAQ
Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2024 and Business Update
News Preview
Exploration and evaluation of strategic alternatives continue Exploration and evaluation of strategic alternatives continue...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.08.2024
PRTG
LISTED
NASDAQ
Portage Biotech Reports Fiscal Year-Ended March 31, 2024 Financial Results and Business Update
News Preview
WESTPORT, Conn., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of novel multi-targeted therapies for use as monotherapy and in combination, today announced its financial results for the fiscal year ended March 31, 2024....
Themefolio
Profiler
Peergroup
© Newsfile
29.06.2021
PRTG
LISTED
NASDAQ
Portage Biotech Added to Russell 2000(R) Index
News Preview
Westport, Connecticut--(Newsfile Corp. - June 29, 2021) - Portage Biotech Inc., (NASDAQ: PRTG) ("Portage" or the "Company") a clinical-stage immuno-oncology company focused on the development of therapies targeting cancer treatment resistance, today announced that the Company has been added to the Russell 2000 Index at the conclusion of the...
Themefolio
Profiler
Peergroup
© Newsfile
24.06.2021
PRTG
LISTED
NASDAQ
Portage Biotech Inc. Announces Pricing of Public Offering of 1,000,000 Ordinary Shares
News Preview
Westport, Connecticut--(Newsfile Corp. - June 24, 2021) - Portage Biotech Inc. (NASDAQ: PRTG) ("Portage" or the "Company") a clinical-stage immuno-oncology company focused on the development of therapies and treatments targeting cancer treatment resistance, today announced that it has priced its previously announced underwritten public offering of...
Themefolio
Profiler
Peergroup
© Newsfile
23.06.2021
PRTG
LISTED
NASDAQ
Portage Biotech Inc. Announces Proposed Offering of Ordinary Shares
News Preview
Westport, Connecticut--(Newsfile Corp. - June 23, 2021) - Portage Biotech Inc. (NASDAQ: PRTG) ("Portage" or the "Company") a clinical-stage immuno-oncology company focused on the development of therapies and treatments targeting cancer treatment resistance, today announced that it has commenced an underwritten public offering of its ordinary shares...
Themefolio
Profiler
Peergroup
© Newsfile
02.06.2021
PRTG
LISTED
NASDAQ
Portage Biotech Highlights Safety and Survival Data from Intensity Therapeutics' IT-01 Study of INT230-6 (PORT-1) at ASCO 2021 Annual Meeting
News Preview
- Data from the IT-01 trial demonstrate the safety of INT230-6 (PORT-1) as both a monotherapy and in combination with checkpoint inhibitors in solid tumors - Survival data looks favorable compared to similar historical populations, balanced for prognostic factorsWestport, Connecticut--(Newsfile Corp. - June 2, 2021) - Portage Biot...
Themefolio
Profiler
Peergroup
© Newsfile
16.04.2021
PRTG
LISTED
NASDAQ
Portage Biotech Announces Voluntary Delisting from the Canadian Securities Exchange
News Preview
Common shares will be consolidated on the Nasdaq exchange where shareholders can continue trading under the symbol "PRTG"Westport, Connecticut--(Newsfile Corp. - April 16, 2021) - Portage Biotech Inc., (NASDAQ: PRTG) (CSE: PBT.U) ("Portage" or the "Company") a clinical-stage immuno-oncology company focused on the development of therapies targ...
Themefolio
Profiler
Peergroup
© Newsfile
08.04.2021
PRTG
LISTED
NASDAQ
Portage Biotech Highlights First Patient Dosed in PRECIOUS-01 Study of PORT-3 for the Treatment of NY-ESO-1 Positive Solid Tumors
News Preview
- Novel platform allows co-targeting of iNKT cells and tumor antigens in a single product- Trial marks the first milestone in a comprehensive clinical development plan to evaluate iNKT agonists to improve outcomes in a variety of solid tumors Westport, Connecticut--(Newsfile Corp. - April 8, 2021) - Portage Biotech Inc. (NASDAQ:...
Themefolio
Profiler
Peergroup
© Newsfile
25.03.2021
PRTG
LISTED
NASDAQ
Portage Biotech Highlights Initiation of the Invincible Trial, a Phase 2 Early Stage Breast Cancer Study from Intensity Therapeutics
News Preview
- The INVINCIBLE trial is a phase 2 study with a primary endpoint one month after starting treatment - Eight other phase 2 clinical data reads are expected from INT230-6 (PORT-1) over the next 24 monthsWestport, Connecticut--(Newsfile Corp. - March 25, 2021) - Portage Biotech Inc. (NASDAQ: PRTG) (CSE: PBT.U) ("Portage" or the "Company...
Themefolio
Profiler
Peergroup
© Newsfile
04.03.2021
PRTG
LISTED
NASDAQ
Portage Biotech Divests Portage Pharmaceuticals Limited to Juvenescence Ltd
News Preview
- Out-licensing agreement facilitates focus on the Company's immuno-oncology assets -- Portage may be entitled to up to USD $244 million in future milestone payments -Toronto, Ontario--(Newsfile Corp. - March 4, 2021) - Portage Biotech Inc. (NASDAQ: PRTG) (CSE: PBT.U) ("Portage" or the "Company") a clinical stage immuno-oncology company acceleratin...
Themefolio
Profiler
Peergroup
© Newsfile
02.03.2021
PRTG
LISTED
NASDAQ
Portage Announces Filing of Third Quarter Financial Statements
News Preview
Toronto, Ontario--(Newsfile Corp. - March 2, 2021) - Portage Biotech Inc. (NASDAQ: PRTG) (CSE: PBT.U) ("Portage" or the "Company") a clinical stage immune-oncology company accelerating research and development to overcome immune resistance, today announced the filing of its interim financial statements and related management's analysis and discuss...
Themefolio
Profiler
Peergroup
© Newsfile
25.02.2021
PRTG
LISTED
NASDAQ
Portage Commences Trading on Nasdaq
News Preview
Trading of ordinary shares begins under the symbol "PRTG"Toronto, Ontario--(Newsfile Corp. - February 25, 2021) - Portage Biotech Inc. (CSE: PBT.U) (NASDAQ: PRTG) ("Portage" or the "Company") a clinical stage immuno-oncology company accelerating research and development to overcome immune resistance, today announced the commencement of...
Themefolio
Profiler
Peergroup
© Newsfile
11.02.2021
PRTG
LISTED
NASDAQ
Portage Biotech Provides Research and Development Update and Announces NASDAQ Listing Approval
News Preview
-- Company to advance three clinical-stage programs in pipeline ---- Portage has received approval and is preparing for NASDAQ listing --Toronto, Ontario--(Newsfile Corp. - February 11, 2021) - Portage Biotech Inc. (CSE: PBT.U) (OTC Pink: PTGEF) ("Portage" or the "Company") today announced its 2021 research and development goals, including advancin...
Themefolio
Profiler
Peergroup
© Newsfile
16.10.2020
PRTG
LISTED
NASDAQ
Portage Announces Filing of Q1 Interim Financial Statements; Correction to SalvaRX Loan Note Settlement Announcement
News Preview
Toronto, Ontario--(Newsfile Corp. - October 16, 2020) - Portage Biotech Inc. (CSE: PBT.U) (OTC Pink: PTGEF) ("Portage" or the "Company") announces that the Company has filed its interim financial statements and related management's discussion and analysis for the three-month period ending June 30, 2020 and related delivery requirements (the "Q1 Fi...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
